Are Patients With Multiple Sclerosis (Ms) at Higher Risk of Covid-19 Infection?

Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):

Share this content! On (X network) By

Are Patients With Multiple Sclerosis (Ms) at Higher Risk of Covid-19 Infection? Publisher Pubmed

Ghajarzadeh M¹ ; Bonavita S²

Show Affiliations

1. Universal Council of Epidemiology (UCE), Universal Scientific Education and Research Network (USERN), Tehran University of Medical Sciences, Tehran, Iran
2. Department of Advanced Medical and Surgical Sciences, University of Campania â€œLuigi Vanvitelliâ€�, Piazza Miraglia, 2, Naples, 80138, Italy

Source: Neurological Sciences Published:2020

Abstract

[No abstract available]

Related Docs

View other Related Docs

1. The Immunological Therapeutic Strategies for Controlling Multiple Sclerosis: Considerations During the Covid-19 Pandemic, Biomolecules (2021)

2. The Prevalence of Covid-19 Infection in Patients With Multiple Sclerosis (Ms): A Systematic Review and Meta-Analysis, Neurological Sciences (2021)

3. Cardiovascular Diseases Burden in Covid-19: Systematic Review and Meta-Analysis, American Journal of Emergency Medicine (2021)

4. Pharmacological Treatments of Covid-19, Pharmacological Reports (2020)

5. Clinical Course and Outcome in Diabetic Patients With Covid-19, Immunopathologia Persa (2021)

6. Predictors of Catching Covid-19 Infection During Pandemic Stage in Patients With Multiple Sclerosis (Ms), International Journal of Preventive Medicine (2022)

7. Geriatric Challenges in the New Coronavirus Disease-19 (Covid-19) Pandemic: A Systematic Review, Medical Journal of the Islamic Republic of Iran (2020)

8. Immunomodulatory Effects of Vitamin D in Influenza Infection, Current Immunology Reviews (2018)

Experts (# of related papers)

View all Related Experts

Nima Rezaei (8)

Mohammadreza Salehi (7)

Other Related Docs

9. The Potential of Cannabidiol for Acute Respiratory Distress Syndrome in Covid-19, Current Pharmaceutical Design (2023)

10. Critical Complications of Covid-19: A Descriptive Meta-Analysis Study, Reviews in Cardiovascular Medicine (2020)

11. Covid-19 and Multiorgan Failure: A Narrative Review on Potential Mechanisms, Journal of Molecular Histology (2020)

12. Clinical Characteristics and Outcomes of 905 Covid-19 Patients Admitted to Imam Khomeini Hospital Complex in the Capital City of Tehran, Iran, Archives of Iranian Medicine (2020)

13. Lymphopenia in Covid-19: Therapeutic Opportunities, Cell Biology International (2020)

14. The Persistence Time of Sars-Cov-2 Rna in Hospitalized Covid-19 Patients: A Prospective Study, Infectious Disorders - Drug Targets (2022)

15. Ace2 Correlates With Immune Infiltrates in Colon Adenocarcinoma: Implication for Covid-19, International Immunopharmacology (2021)

16. Central Nervous System Manifestations in Covid-19 Patients: A Systematic Review and Meta-Analysis, Brain and Behavior (2021)

17. A Review of Covid-19 Vaccines and Major Considerations for Diabetic Patients, Biotechnology and Applied Biochemistry (2022)

18. Acute Cardiac Injury in Covid-19: A Systematic Review and Meta-Analysis, Archives of Iranian Medicine (2020)

19. Cardiovascular Considerations in Treating Patients With Coronavirus Disease 2019 (Covid-19), Journal of Cardiovascular Pharmacology (2020)

20. Conquering the Cytokine Storm in Covid-19-Induced Ards Using Placenta-Derived Decidua Stromal Cells, Journal of Cellular and Molecular Medicine (2021)

21. Fungal and Bacterial Co-Infections of the Respiratory Tract Among Patients With Covid-19 Hospitalized in Intensive Care Units, Gene Reports (2022)

22. Covid-19’S Immuno-Pathology and Cardiovascular Diseases, Journal of Investigative Medicine (2023)

23. Clinical Symptoms and Types of Samples Are Critical Factors for the Molecular Diagnosis of Symptomatic Covid-19 Patients: A Systematic Literature Review, International Journal of Microbiology (2021)

24. Factors Associated With Mortality in Covid-19 Patients: A Systematic Review and Meta-Analysis, Iranian Journal of Public Health (2020)

25. Variants in Ace2; Potential Influences on Virus Infection and Covid-19 Severity, Infection# Genetics and Evolution (2021)

26. Hematologic Predictors of Mortality in Hospitalized Patients With Covid-19: A Comparative Study, Hematology (United Kingdom) (2020)

27. Safety and Efficacy Study of Allogeneic Human Menstrual Blood Stromal Cells Secretome to Treat Severe Covid-19 Patients: Clinical Trial Phase I & Ii, Stem Cell Research and Therapy (2022)

28. The Clinical Value of Two Combination Regimens in the Management of Patients Suffering From Covid-19 Pneumonia: A Single Centered, Retrospective, Observational Study, DARU# Journal of Pharmaceutical Sciences (2020)

29. Risk Factors of Death in Mechanically Ventilated Covid-19 Patients: A Multi-Center Study From Iran, Acta Medica Iranica (2023)

30. Liver Injury Is Associated With Severe Coronavirus Disease 2019 (Covid-19) Infection: A Systematic Review and Meta-Analysis of Retrospective Studies, Hepatology Research (2020)

31. Nsaids and Covid-19: A New Challenging Area, Pharmaceutical Sciences (2020)

32. Case Fatality Rate of Covid-19: A Systematic Review and Meta-Analysis, Journal of Preventive Medicine and Hygiene (2021)

33. Potential of Therapeutic Plasmapheresis in Treatment of Covid-19 Patients: Immunopathogenesis and Coagulopathy, Transfusion and Apheresis Science (2020)

34. Clinical Characteristics and Outcome of Hospitalized Covid-19 Patients With Diabetes: A Single-Center, Retrospective Study in Iran, Diabetes Research and Clinical Practice (2020)

35. The Biochemical Parameters and Vitamin D Levels in Icu Patients With Covid-19: A Cross-Sectional Study, Endocrine# Metabolic and Immune Disorders - Drug Targets (2021)

36. Positive Association Between Severity of Covid-19 Infection and Liver Damage: A Systematic Review and Meta-Analysis, Gastroenterology and Hepatology from Bed to Bench (2020)

37. Immune Profiling of Sars-Cov-2; What We Know and What We Don’T Know, Iranian Journal of Allergy# Asthma and Immunology (2023)

38. Invasive Airway Intubation in Covid-19 Patients; Statistics, Causes, and Recommendations: A Review Article, Anesthesiology and Pain Medicine (2021)

39. Covid-19 Pandemic and Biological Therapy in Rheumatologic Disorders: How to Deal With?, Reumatismo (2020)

40. Covid-19: A Systematic Review and Update on Prevention, Diagnosis, and Treatment, MedComm (2022)

41. Risk and Predictors of In-Hospital Mortality From Covid-19 in Patients With Diabetes and Cardiovascular Disease, Diabetology and Metabolic Syndrome (2020)

42. A Comparative Analysis of Clinical Characteristics and Laboratory Findings of Covid-19 Between Intensive Care Unit and Non-Intensive Care Unit Pediatric Patients: A Multicenter, Retrospective, Observational Study From Iranian Network for Research in Viral Diseases (Inrvd), Frontiers in Emergency Medicine (2021)

43. The Association Between Acute Cardiac Injury and Outcomes of Hospitalized Patients With Covid-19: Long-Term Follow-Up Results From the Sina Hospital Covid-19 Registry, Iran, Journal of Tehran University Heart Center (2023)

44. Psycho-Neuroendocrine-Immune Aspects of Covid-19 and Its Relationship With Post-Traumatic Stress Disorder, Current Psychiatry Research and Reviews (2024)

45. Vitamin D and Covid-19: From Potential Therapeutic Effects to Unanswered Questions, Reviews in Medical Virology (2021)

46. Kidney Diseases and Covid-19 Infection: Causes and Effect, Supportive Therapeutics and Nutritional Perspectives, Heliyon (2021)

47. Primary Immunodeficiency Diseases in Covid-19 Pandemic: A Predisposing or Protective Factor?, American Journal of the Medical Sciences (2020)

48. Opportunistic Fungal Infections in the Epidemic Area of Covid-19: A Clinical and Diagnostic Perspective From Iran, Mycopathologia (2020)

49. Serum C-Reactive Protein Greater Than 75 Mg/Dl As an Early Available Laboratory Predictor of Severe Covid-19: A Systematic Review, Immunity# Inflammation and Disease (2023)

50. Immune-Epidemiological Parameters of the Novel Coronavirus–A Perspective, Expert Review of Clinical Immunology (2020)

Style	Citing Format
MLA	Ghajarzadeh M, Bonavita S. "Are Patients With Multiple Sclerosis (Ms) at Higher Risk of Covid-19 Infection?." Neurological Sciences, vol. 41, no. 9, 2020, pp. 2315-2316.
APA	Ghajarzadeh M, Bonavita S (2020). Are Patients With Multiple Sclerosis (Ms) at Higher Risk of Covid-19 Infection?. Neurological Sciences, 41(9), 2315-2316.
Chicago	Ghajarzadeh M, Bonavita S. "Are Patients With Multiple Sclerosis (Ms) at Higher Risk of Covid-19 Infection?." Neurological Sciences 41, no. 9 (2020): 2315-2316.
Harvard	Ghajarzadeh M, Bonavita S (2020) 'Are Patients With Multiple Sclerosis (Ms) at Higher Risk of Covid-19 Infection?', Neurological Sciences, 41(9), pp. 2315-2316.
Vancouver	Ghajarzadeh M, Bonavita S. Are Patients With Multiple Sclerosis (Ms) at Higher Risk of Covid-19 Infection?. Neurological Sciences. 2020;41(9):2315-2316.
BibTex	@article{ author = {Ghajarzadeh M and Bonavita S}, title = {Are Patients With Multiple Sclerosis (Ms) at Higher Risk of Covid-19 Infection?}, journal = {Neurological Sciences}, volume = {41}, number = {9}, pages = {2315-2316}, year = {2020} }
RIS	TY - JOUR AU - Ghajarzadeh M AU - Bonavita S TI - Are Patients With Multiple Sclerosis (Ms) at Higher Risk of Covid-19 Infection? JO - Neurological Sciences VL - 41 IS - 9 SP - 2315 EP - 2316 PY - 2020 ER -